Professors Deborah Gill and Stephen Hyde, together with their UK Cystic Fibrosis Gene Therapy Consortium partners, have teamed up with Boehringer Ingelheim and Oxford Biomedica to develop gene therapy for cystic fibrosis.
Computational Biologist Stephen Taylor and his team were awarded an Innovation grant to develop a software package that allows researchers to use virtual reality for scientific research and public engagement.
A collaborative study between the Kennedy Institute and MRC Weatherall Institute of Molecular Medicine (MRC WIMM) identifies a new pathway that limits the severity of inflammatory skin disease.
The annual call for nominations for the Title of Associate Professor (AP) and University Research Lecturer (URL) has just been announced. These are prestigious titles within the University and we are working to ensure we are formally recognising the achievements of our staff.
Congratulations to Professor Graham Ogg and Associate Professor Tatjana Sauka-Spengler \u2013 the first recipients of the RDM Awards for Excellent Supervision. The Awards were presented at the RDM Symposium on Monday 19 March 2018.
Congratulations to Prof Graham Ogg and Prof Paresh Vyas who have been named National Institute of Health Research (NIHR) Senior Investigators in recognition of their \u201coutstanding contribution to clinical and applied health and social care research\u201d. In addition, Prof Mark McCarthy has had his Senior Investigator award renewed. This is a tremendous achievement for all of them as these are highly competitive and prestigious awards
The Radcliffe Department of Medicine has launched a new initiative \u2013 the Oxford Centre for Haematology (OCH). Through this virtual Centre we aim to promote integration between academic and clinical haematology programmes in the University and Oxford University Hospital NHS Foundation Trust and thereby capitalise on scientific opportunities to transform our understanding of haemopoiesis and blood diseases.
Congratulations to Prof Jackie Boultwood and Dr Andrea Pellagatti, who have been awarded a project grant from Leuka \u2013 a leading leukaemia research charity. Their work will focus on Chronic myelomonocytic leukaemia (CMML), a blood cancer with a poor prognosis and limited treatment options.
Congratulations to Huw Colin-York, Quentin Ferry and Thomas Riffelmacher, who won 2017\u2019s RDM Graduate Prize. All three students displayed research excellence during their DPhil studies and have helped to progress their respective fields.
Many congratulations to Dr Robert Beagrie, a postdoc with Prof Doug Higgs at the MRC Molecular Haematology Unit, who has been awarded a prestigious Sir Henry Wellcome Postdoctoral Fellowship. The four-year award offers recently qualified postdoctoral researchers the opportunity to start independent research careers.
Researchers at the MRC Weatherall Institute of Molecular Medicine have developed a new platform based on CRISPR/Cas9 technology, to alter the way human cells respond to external signals.
The Curiosity Carnival rolled into town on 29 September for a festival of all things research. Over 30 researchers from across RDM took part in the largest public engagement event Oxford has ever staged.
New research shows that blood donors could safely give blood more frequently than is allowed at present. At the moment in the UK men can give blood every 12 weeks, women every 16 weeks. The new research demonstrates that in certain situations and for certain donors, shortening the donation interval is a viable approach for blood services to take.
Congratulations to Prof Marella de Bruijn (Professor of Developmental Haematopoiesis), Prof Deborah Gill (Professor of Gene Medicine) and Prof Charalambos Antoniades (Professor of Cardiovascular Medicine) who were all awarded the title of full professor in the recent Recognition of Distinction Exercise.
Staff across RDM have been recognised in the Medical Sciences Division\u2019s Teaching Excellence Awards 2017. The Teaching Excellence Awards scheme recognises and rewards excellence in teaching, the organisation and development of teaching, and support for teaching and learning, within a research-intensive environment.
The MRC Weatherall Institute of Molecular Medicine (MRC WIMM) invited Oxford East MP Anneliese Dodds to learn more about cutting edge research taking place in her constituency and learn more from researchers about the challenges they face. The visit took place on 30 August.
![](\"https://www.rdm.ox.ac.uk/news/gene-therapy-for-cystic-fibrosis/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n